FBT ETF

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on 06/19/2006.

The First Trust NYSE Arca Biotechnology ETF (FBT) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

Making its debut on 06/19/2006, smart beta exchange traded fund First Trust NYSE Arca Biotechnology ETF (FBT) provides investors broad exposure to the Health Care ETFs category of the market.

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.

Biotech stocks have not yet reached their peak levels from 2021, making them an attractive opportunity for investors to catch up. The First Trust NYSE Arca Biotechnology Index Fund ETF tracks the performance of the NYSE Arca Biotechnology Index by investing evenly in 30 top biotech companies, providing diversified exposure to the sector's growth potential.

Created to offer extensive coverage of the Health Care ETFs sector, the First Trust NYSE Arca Biotechnology ETF (FBT) is a smart beta exchange traded fund that debuted on 06/19/2006.

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund launched on 06/19/2006.

The First Trust NYSE Arca Biotechnology ETF (FBT) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.